Literature DB >> 28987224

Controversies in Traditional Oral and Maxillofacial Reconstruction.

John S Vorrasi1, Antonia Kolokythas2.   

Abstract

Traditional reconstruction of the head and neck and significantly evolved over the last 20 to 30 years with advances in microvascular surgery, biologic materials such as bone morphogenic protein, and dental implant predictability. Earlier and more definitive reconstruction can now be achieved with combining therapies, allowing patients immediate restoration of function and improved cosmetics. Antiresorptive medications, such as Denosumab and bisphosphonates, have complicated bony reconstruction treatments with altered biology and less-predictable results. Virtual surgical planning is a major advancement for reconstruction pretreatment planning and designing of intraoperative tools to expedite the operation and achieve more predictable results. Published by Elsevier Inc.

Entities:  

Keywords:  Nonvascularized graft; Reconstruction; Virtual surgical planning

Mesh:

Substances:

Year:  2017        PMID: 28987224     DOI: 10.1016/j.coms.2017.06.003

Source DB:  PubMed          Journal:  Oral Maxillofac Surg Clin North Am        ISSN: 1042-3699            Impact factor:   2.802


  3 in total

1.  rhBMP2 alone does not induce macrophage polarization towards an increased inflammatory response.

Authors:  Emily L Durham; Rajiv Kishinchand; Zachary J Grey; James J Cray
Journal:  Mol Immunol       Date:  2019-11-20       Impact factor: 4.407

Review 2.  Clinical utility of hyperbaric oxygen therapy in dentistry.

Authors:  Kaitlyn Re; Shrey Patel; Jason Gandhi; Yiji Suh; Inefta Reid; Gunjan Joshi; Noel L Smith; Sardar Ali Khan
Journal:  Med Gas Res       Date:  2019 Apr-Jun

Review 3.  Bone Tissue Regeneration in the Oral and Maxillofacial Region: A Review on the Application of Stem Cells and New Strategies to Improve Vascularization.

Authors:  Vivian Wu; Marco N Helder; Nathalie Bravenboer; Christiaan M Ten Bruggenkate; Jianfeng Jin; Jenneke Klein-Nulend; Engelbert A J M Schulten
Journal:  Stem Cells Int       Date:  2019-12-30       Impact factor: 5.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.